105836-96-2 Usage
Appearance
Brightly colored yellow solid 2,8-dibromooxanthrene has a vivid yellow color and is a solid at room temperature.
Usage
Manufacturing of dyes and pigments This compound is utilized in the production of various dyes and pigments for different industries.
Chemical family
Xanthene 2,8-dibromooxanthrene belongs to the xanthene family, which is a group of organic compounds.
Derivation
Substitution of two bromine atoms at the 2 and 8 positions This compound is derived from xanthene by replacing two hydrogen atoms with bromine atoms at specific positions on the molecule.
Hazardous nature
Potential health and environmental risks 2,8-dibromooxanthrene is considered hazardous, and proper handling precautions should be taken to minimize exposure and environmental contamination.
Stability
High heat and light stability This compound is known for its ability to withstand high temperatures and resist degradation from exposure to light, making it suitable for various industrial applications.
Industrial applications
Textile and paper production Due to its stability, 2,8-dibromooxanthrene is used in industries such as textile and paper production to provide color and stability to the final products.
Check Digit Verification of cas no
The CAS Registry Mumber 105836-96-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,8,3 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 105836-96:
(8*1)+(7*0)+(6*5)+(5*8)+(4*3)+(3*6)+(2*9)+(1*6)=132
132 % 10 = 2
So 105836-96-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H6Br2O2/c13-7-1-3-9-11(5-7)16-12-6-8(14)2-4-10(12)15-9/h1-6H
105836-96-2Relevant articles and documents
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity
Yu, Wensheng,Coburn, Craig A.,Yang, De-Yi,Meinke, Peter T.,Wong, Michael,Rosenblum, Stuart B.,Chen, Kevin X.,Njoroge, George F.,Chen, Lei,Dwyer, Michael P.,Jiang, Yueheng,Nair, Anilkumar G.,Selyutin, Oleg,Tong, Ling,Zeng, Qingbei,Zhong, Bin,Ji, Tao,Hu, Bin,Agrawal, Sony,Xia, Ellen,Zhai, Ying,Liu, Rong,Kong, Rong,Ingravallo, Paul,Asante-Appiah, Ernest,Nomeir, Amin,Fells, James,Kozlowski, Joseph A.
, p. 3158 - 3162 (2016/06/13)
HCV NS5A inhibitors have demonstrated impressive in vitro potency profiles in HCV replicon assays and robust HCV RNA titer reduction in the clinic making them attractive components for inclusion in an all oral fixed dose combination regimen for the treatment of HCV infection. Herein, we describe research efforts that led to the discovery of a series of fused tricyclic core containing HCV NS5A inhibitors such as 24, 39, 40, 43, and 44 which have pan-genotype activity and are orally bioavailable in the rat.
SYNTHESIS AND PROPERTIES OF SOME BROMINE-CONTAINING DIBENZO-p-DIOXINS
Kuntsevich, A. D.,Golovkov, V. F.,Chernov, S. A.,Rembovskii, V. R.,Troshkin, N. M.,Baulin, S. I.
, p. 225 - 229 (2007/10/02)
-
EFFECT OF THE CROWN ETHER 18-CROWN-6-ON CHLORINATION OF DIBENZO-p-DIOXIN AND ITS DERIVATIVES
Kuntsevich, A. D.,Golovkov, V. F.,Chernov, S. A.
, p. 245 - 247 (2007/10/02)
-